Max Robotics — Global Service Robot Directory + US Certification

About

Shawn Dason is a leading urologic oncologist whose work centers on advancing robotic surgery for bladder and prostate cancers. His primary research focuses on refining robot-assisted radical cystectomy (RARC) and intracorporeal urinary diversion (ICUD)—complex procedures that replace the bladder after its removal. Dason’s major contributions include systematically reviewing and standardizing contemporary techniques and outcomes for these surgeries, as demonstrated in his highly cited 2017 review (18 citations), which has become a key resource for surgeons adopting these minimally invasive approaches. He has also critically examined the learning curve for robot-assisted laparoscopic radical prostatectomy (RARP), analyzing positive surgical margin rates to improve surgical precision and patient outcomes (15 citations). Beyond technique, Dason investigates health policy, notably analyzing Medicare reimbursement trends in urologic oncology from 2002 to 2024, highlighting financial challenges facing the field. His work bridges surgical innovation with practical implementation, helping to shape best practices in robotic urologic oncology. With publications spanning technical updates, outcomes research, and healthcare economics, Dason’s research directly impacts how surgeons train, operate, and navigate the evolving landscape of cancer care.